# Trial to Investigate GZ21T in Healthy Volunteers

> **NCT06888362** · PHASE1 · COMPLETED · sponsor: **Genzada Pharmaceuticals USA, Inc.** · enrollment: 41 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** GZ21T

## Key facts

- **NCT ID:** NCT06888362
- **Lead sponsor:** Genzada Pharmaceuticals USA, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-19
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2026-01-28

## Collaborators

- CTC Clinical Trial Consultants AB

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06888362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06888362, "Trial to Investigate GZ21T in Healthy Volunteers". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT06888362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*